Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessAnnouncementsLifeline Drugs revised outcome of board meeting

    Lifeline Drugs revised outcome of board meeting

    Lifeline Drugs & Pharma has informed BSE that that there was a typographical error in submission of Outcome of Board Meeting held on February 05 2013.

    February 07, 2013 / 17:29 IST

    With reference to the earlier announcement dated February 05, 2013 regarding Outcome of Board Meeting, Lifeline Drugs & Pharma Ltd has now informed BSE that that there was a typographical error in submission of Outcome of Board Meeting held on February 05 2013. The Correct Outcome of Board Meeting should be read as under:- The Board of Directors of the Company at its meeting held on February 05, 2013 have allotted 7,38,000 Equity Shares of Rs. 10/- each for cash at a premium of Rs. 50/- per share under Section 81(1A) of the Companies Act, 1956 pursuant to the authority given by the members in the EOGM held on January 18, 2013.Source : BSE

    Read all announcements in Lifeline Drugs

    first published: Feb 7, 2013 05:29 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347